CDEK by Data4ThePeople

Sign in Sign up

← All organizations

Angiodynamics, Inc.

For profitWebsite ↗

Also known as: Angiodynamics, Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Jul 10, 2024

Timeline

1990s

Jun 1, 1992
Angiodynamics, Inc.— Founded

Drugs by trial phase (6 distinct, 3 trials)

Phase 3 (4 own, 0 via acquisition)

Phase 2 (1 own, 0 via acquisition)

ip-001

Phase 1 (1 own, 0 via acquisition)

pembrolizumab

Indications

Studied for

Pancreatic Neoplasms

Recent trials (3)

NCT06630624CollaboratorPhase 1/Phase 2Jul 10, 2024
NCT06378047CollaboratorPhase 1Apr 10, 2024
NCT03899636Lead sponsorPhase 3May 31, 2019

Details

Founded: Latham, NY, US Jun 1, 1992
Last known activity: Jul 10, 2024